Jiang Xue, Zhao Huanhuan, Li Wei
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Ministry of Education), School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.
Front Bioeng Biotechnol. 2022 Feb 11;10:840395. doi: 10.3389/fbioe.2022.840395. eCollection 2022.
Drug-carrying nanoparticles have obtained great attention for disease treatments due to the fact that they can improve drug solubility, provide drug protection and prolong release duration, thus enhancing drug bioavailability and increasing therapeutic efficacy. Although nanoparticles containing drugs can be administered different routes such as oral, intravenous and ocular, transdermal delivery of nanoparticles mediated by microneedles has attracted considerable interest due to the capability of circumventing enzymatic degradation caused by gastrointestinal track, and increasing patient compliance by reducing pain associated with hypodermic injection. In this review, we first introduce four types of nanoparticles that were used for drug delivery, and then summarize strategies that have been employed to facilitate delivery of drug-loaded nanoparticles microneedles. Finally, we give a conclusion and provide our perspectives on the potential clinical translation of microneedle-facilitated nanoparticles delivery.
载药纳米颗粒因其能够提高药物溶解度、提供药物保护并延长释放时间,从而提高药物生物利用度和增强治疗效果,在疾病治疗方面受到了广泛关注。尽管含药纳米颗粒可以通过口服、静脉注射和眼部给药等不同途径给药,但微针介导的纳米颗粒经皮给药因其能够规避胃肠道引起的酶降解,并通过减轻皮下注射相关疼痛来提高患者依从性而备受关注。在本综述中,我们首先介绍用于药物递送的四种纳米颗粒类型,然后总结为促进载药纳米颗粒通过微针递送而采用的策略。最后,我们给出结论,并就微针促进纳米颗粒递送的潜在临床转化提供我们的观点。